<p>Wild type or p53-silenced (p53KD) PVTT-1 cells were treated with or without insulin (10 μg/ml) and/or TGF-β1 (5 ng/ml) for 48 h before harvesting for immunoblotting using the antibodies as indicated. The cells were either overexpressed with ICAT <b>(A</b>) or treated with 1 µM of XAV939 for 48 h (<b>B</b>). The morphological changes of liver cancer cells were also analyzed (<b>C</b>). The cells were fixed and subjected to immunofluorescence staining to detect expression of E-cadherin, Snail and vimentin (red). The nuclei were stained with Hoechest 33342 (blue). The pictures of bright field were also shown.</p
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
Epithelial to mesenchymal transition (EMT) is an integral process in the progression of many epithel...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>PVTT-1 cells expressing GFP-tagged p53 shRNA (p53KD) and/or ICAT were treated with insulin (10 μg...
<p>PVTT-1 cells with or without p53 knockdown (p53KD) were treated with insulin (10 μg/ml) and/or TG...
<p>PVTT-1 cells selected for the expression of ICAT and p53 shRNA (p53KD) were injected into the lef...
<div><p>Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle ...
Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle in curin...
<p><b>A</b>-<b>C</b>, Western blots were prepared with extracts from parental MDCK cells (lane 1), p...
<div><p>(A) Real-time PCR analysis of E-cadherin, N-cadherin and Vimentin mRNA levels and (B) Protei...
<p>High expression of β-Catenin and Vimentin and low E-cadherin expression in U251 and U87 cells was...
<p>The cells were transfected with a negative control shRNA (ctrl-shRNA) or a shRNA targeting p38α (...
<p>(A) RT-PCR analysis for p53 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in C2C12 cells t...
Chemoresistance is a major problem in the treatment of hepatocellular carcinoma. Certain p53 mutants...
<p>(A) HCT116 cells were treated with or without TNFα (20 ng/ml) for 4 days. Cell morphological chan...
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
Epithelial to mesenchymal transition (EMT) is an integral process in the progression of many epithel...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>PVTT-1 cells expressing GFP-tagged p53 shRNA (p53KD) and/or ICAT were treated with insulin (10 μg...
<p>PVTT-1 cells with or without p53 knockdown (p53KD) were treated with insulin (10 μg/ml) and/or TG...
<p>PVTT-1 cells selected for the expression of ICAT and p53 shRNA (p53KD) were injected into the lef...
<div><p>Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle ...
Hepatocellular carcinoma (HCC) is one of the most malignant tumors and the biggest obstacle in curin...
<p><b>A</b>-<b>C</b>, Western blots were prepared with extracts from parental MDCK cells (lane 1), p...
<div><p>(A) Real-time PCR analysis of E-cadherin, N-cadherin and Vimentin mRNA levels and (B) Protei...
<p>High expression of β-Catenin and Vimentin and low E-cadherin expression in U251 and U87 cells was...
<p>The cells were transfected with a negative control shRNA (ctrl-shRNA) or a shRNA targeting p38α (...
<p>(A) RT-PCR analysis for p53 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in C2C12 cells t...
Chemoresistance is a major problem in the treatment of hepatocellular carcinoma. Certain p53 mutants...
<p>(A) HCT116 cells were treated with or without TNFα (20 ng/ml) for 4 days. Cell morphological chan...
<p>(A) The phosphorylation profile of p53 protein following MNNG treatment. TW01 and NA cells were t...
Epithelial to mesenchymal transition (EMT) is an integral process in the progression of many epithel...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...